# Mirion Technologies, Inc. > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/en/companies/Mirion Technologies, Inc.). ## Overview Mirion Technologies designs radiation detection, measurement, monitoring, and analysis products, software, and services used in nuclear, medical, defense, and scientific applications. The company helps customers safely use ionizing radiation in highly regulated environments, with a business built around technical qualification, reliability, and long-lived installed bases. ## Products & services • Radiation detection and monitoring systems • Dosimetry products and services • Nuclear power plant instrumentation and safety solutions • Medical imaging and cancer-care radiation safety tools • Radiation analysis software and services • Engineered solutions for SMRs and nuclear facilities - **Nuclear & Safety** (72%) — Radiation measurement, monitoring, and safety products for nuclear power, labs, defense, and industrial users. - **Medical** (28%) — Radiation safety and dosimetry solutions for cancer centers, imaging facilities, and healthcare workers. - Radiation detection and monitoring systems - Dosimetry products and services - Nuclear power plant instrumentation and safety solutions - Medical imaging and cancer-care radiation safety tools - Radiation analysis software and services - Engineered solutions for SMRs and nuclear facilities ## Customers Mirion sells to customers that operate in regulated, radiation-intensive environments where precision and compliance matter more than low cost. Its customer base includes nuclear power plants, SMR developers, government and defense agencies, laboratories, radiopharmaceutical manufacturers, hospitals, and cancer centers. Many purchases are driven by product qualification, reliability, service support, and long-term supplier relationships. - **Nuclear power operators** (primary) — Buy plant instrumentation, monitoring, and safety systems for operating fleets, upgrades, and decommissioning. - **SMR developers and new nuclear entrants** (primary) — Buy highly engineered solutions and qualification-ready products for new reactor builds. - **Medical centers and hospitals** (primary) — Buy dosimetry, imaging safety, and radiation protection tools to support patient and staff safety. - **Government and defense customers** (secondary) — Buy detection and monitoring systems for mission-critical radiation safety and security use cases. - **Laboratories and research institutions** (secondary) — Buy measurement, analysis, and monitoring products for scientific and industrial radiation applications. - Nuclear power plants buy monitoring and safety systems for operations and upgrades - SMR developers buy engineered solutions for new reactor designs - Defense and government agencies buy radiation detection and protection tools - Hospitals and cancer centers buy dosimetry and radiation safety products - Labs and research institutes buy measurement and analysis equipment - Radiopharmaceutical makers buy radiation monitoring for production and handling ## Geography Mirion is headquartered in Atlanta and operates across North America, Europe, and Asia, with facilities and sales offices in multiple countries including Canada, the UK, France, Germany, Finland, China, Belgium, the Netherlands, Estonia, Japan, and South Korea. The business is globally distributed because its customers are tied to local nuclear fleets, healthcare systems, and regulated industrial markets, while sanctions, tariffs, and export controls can affect cross-border sales and project execution. - Headquartered in Atlanta, Georgia, with global operations - Sales offices across North America, Europe, and Asia - Manufacturing and operating footprint in Europe and Asia - Revenue exposure to nuclear, medical, and defense markets worldwide - Russia-related projects create geopolitical and sanctions exposure ## Strategy Mirion is expanding its installed base and product breadth through acquisitions, cross-selling, and deeper penetration of regulated end markets. The Paragon acquisition strengthens its U.S. nuclear power and SMR position, while ongoing R&D and product qualification support long-cycle customer retention and new design wins. - **Integrate Paragon and expand U.S. nuclear power coverage** (short-term) — Adds engineered solutions for large reactors and SMRs and deepens the U.S. market position. - **Grow through cross-selling and installed-base upgrades** (medium-term) — The company can sell more products into existing nuclear and medical customers with high qualification barriers. - **Sustain technical differentiation through R&D and qualifications** (long-term) — Regulated customers value reliability, compliance, and validated performance over commodity pricing. - Expand nuclear power and SMR offerings through acquisition - Cross-sell across nuclear, medical, and defense end markets - Invest in R&D and product qualification to protect switching costs - Use global sales channels to reach remote and regulated markets - Broaden installed-base service and upgrade revenue ## Risks Mirion’s results depend on regulated end markets, long qualification cycles, and customer willingness to adopt specialized radiation products, which can make demand lumpy and competitive. The company also faces geopolitical and trade risks, including tariffs, export controls, sanctions, and Russia-related exposure, while acquisitions add integration and financing risk. - **Tariffs, trade barriers, and export controls** [high] — The company sells globally and relies on cross-border supply and customer access. - **Russia and Ukraine sanctions exposure** [high] — The company has Russian-related projects, receivables, guarantees, and backlog exposure. - **Acquisition integration risk** [medium] — Expected benefits from Paragon depend on successful integration and retention of customer relationships. - **Regulatory and qualification risk** [medium] — Customers require strict product specifications and approvals, which can delay revenue conversion. - **Competitive pricing and customer concentration in regulated niches** [medium] — Customers compare reliability, technical capability, and price, which can pressure margins. - Tariffs and export controls can raise costs and disrupt international sales - Russia-related projects carry sanctions, collection, and execution risk - Acquisition integration risk could delay expected synergies - Competition is based on reliability, qualification, service, and price - Regulatory changes can delay customer projects and product approvals - Debt and financing needs can constrain future M&A and capital allocation ## Accounting Mirion’s accounting is shaped by long-cycle contracts, acquisitions, and judgment-heavy estimates. Investors should watch revenue recognition timing tied to remaining performance obligations, purchase accounting and goodwill from acquisitions such as Paragon, and valuation allowances and tax-rate effects that can move reported earnings. - **Remaining performance obligations** — Revenue timing and backlog visibility - **Business combinations and purchase accounting** — Goodwill, intangibles, and future impairment risk - **Valuation allowances and tax differences** — Reported tax expense and net income - **Stock-based compensation and debt costs** — Earnings, dilution, and cash flow presentation - Remaining performance obligations affect timing of future revenue recognition - Acquisition accounting can create goodwill and intangible assets subject to impairment - Business combination fair values depend on management estimates - Tax valuation allowances and permanent differences affect the effective tax rate - Stock-based compensation and debt issuance costs affect reported earnings and cash flow --- *Last updated: 2026-04-28T20:27:21.148171+00:00*